Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2

Intern Med. 2023 Jun 1;62(11):1659-1663. doi: 10.2169/internalmedicine.9670-22. Epub 2022 Oct 12.

Abstract

The coexistence of leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) autoantibodies in the same individual is surprisingly often observed. We herein report the first case of LGI1 encephalitis followed by Isaacs syndrome in which LGI1 and CASPR2 antibodies in the serum and cerebrospinal fluid (CSF) were measured during the entire disease course. After the resolution of limbic encephalitis, LGI1 antibodies disappeared from the CSF simultaneously with the appearance of CASPR2 antibodies in the serum. The alternating presence of these pathogenic autoantibodies along with the clinical and phenotypic alternations suggested that LGI1 encephalitis was associated with CASPR2 autoantibody production in the peripheral tissue, leading to CASPR2-associated Isaacs syndrome.

Keywords: Isaacs syndrome; autoantibodies; contactin-associated protein-like 2 (CASPR2); leucine-rich glioma-inactivated 1 (LGI1); limbic encephalitis.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies
  • Contactins
  • Encephalitis* / complications
  • Encephalitis* / diagnosis
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Isaacs Syndrome* / complications
  • Leucine
  • Limbic Encephalitis* / complications

Substances

  • Autoantibodies
  • Leucine
  • Intracellular Signaling Peptides and Proteins
  • Contactins